All Stories

  1. The Challenges of Sex Health Disparities and Differences in Cardiovascular Care
  2. Depression and coronary heart disease: 2018 ESC position paper of the working group of coronary pathophysiology and microcirculation developed under the auspices of the ESC Committee for Practice Guidelines
  3. Vasospastic Angina and its Relationship with the Coronary Microcirculation
  4. Coronary Microcirculation and Ischemic Heart Disease, Today
  5. OBSOLETE: STEMI: Diagnosis
  6. OBSOLETE: STEMI: Prognosis
  7. OBSOLETE: STEMI: Management
  8. Cardiac involvement in myotonic dystrophy: The role of troponins and N-terminal pro B-type natriuretic peptide
  9. Acute Coronary Syndrome: The Risk to Young Women
  10. A Short History of Vasospastic Angina ∗
  11. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS
  12. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
  13. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS
  14. Delayed Care and Mortality Among Women and Men With Myocardial Infarction
  15. Post cardiovascular surgery atrial fibrillation. Biomarkers determining prognosis.
  16. Position paper of the European Society of Cardiology–working group of coronary pathophysiology and microcirculation: obesity and heart disease
  17. Takotsubo Syndrome: Does the Octopus Trap Hide Dangers?
  18. ACUTE CORONARY SYNDROME: THE RISK TO BE YOUNG AND WOMEN
  19. Invasive versus conservative strategy in acute coronary syndromes: The paradox in women's outcomes
  20. Primary percutaneous coronary intervention in octogenarians
  21. The no-reflow phenomenon in the young and in the elderly
  22. Pathophysiology of acute coronary syndromes in the elderly
  23. Association between comorbidities and absence of chest pain in acute coronary syndrome with in-hospital outcome
  24. Factors associated with use of percutaneous coronary intervention among elderly patients presenting with ST segment elevation acute myocardial infarction (STEMI): Results from the ISACS-TC registry
  25. The International Survey of Acute Coronary Syndromes in Transitional Countries (ISACS-TC): 2010–2015
  26. Sex and age differences and outcomes in acute coronary syndromes
  27. Barriers to Risk Stratification Accuracy in Ischemic Heart Disease in Women: The Role of Non-Obstructive Coronary Artery Disease
  28. Editorial (Thematic Issue: What's Behind the Sex Gap in Cardiovascular Mortality?)
  29. Early Invasive Strategy for Unstable Angina: a New Meta-Analysis of Old Clinical Trials
  30. Big data: a new look at old problems
  31. DELAY TO HOSPITAL ADMISSION AND ACUTE CORONARY CARE IN THE ELDERLY AND IN THE VERY ELDERLY
  32. SEX-BASED DIFFERENCES IN SHORT TERM SURVIVAL AFTER PRIMARY PERCUTANEOUS CORONARY INTERVENTION: THE ROLE OF SYSTEM DELAY
  33. Comparison of Early Versus Delayed Oral β Blockers in Acute Coronary Syndromes and Effect on Outcomes
  34. Persisting chest pain in nonobstructive coronary artery disease
  35. Guía ESC 2015 sobre el tratamiento de los síndromes coronarios agudos en pacientes sin elevación persistente del segmento ST
  36. Reperfusion therapy for ST-elevation acute myocardial infarction in Eastern Europe: the ISACS-TC registry
  37. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
  38. Unfractionated heparin–clopidogrel combination in ST-elevation myocardial infarction not receiving reperfusion therapy
  39. Coronary vascular regulation, remodelling, and collateralization: mechanisms and clinical implications on behalf of the working group on coronary pathophysiology and microcirculation
  40. Vasotonic Angina as a Cause of Myocardial Ischemia in Women
  41. SEX-RELATED DIFFERENCES IN ACUTE CORONARY CARE AMONG PATIENTS WITH MYOCARDIAL INFARCTION: THE ROLE OF PRE-HOSPITAL DELAY
  42. DETECTING ACUTE STRESS DISORDERS IN PATIENTS WITH CORONARY ARTERY DISEASE: A PROGNOSTIC EVALUATION OF THE PHQ-9 IN ACUTE CORONARY CARE: FINDINGS FROM THE ISACS-TC STUDY
  43. EARLY VERSUS DELAYED USE OF BETA-BLOCKERS IN ACUTE CORONARY SYNDROMES: A LANDMARK ANALYSIS. FROM THE ISACS-TC STUDY
  44. PARADOXICAL SEX DIFFERENCE IN IN-HOSPITAL OUTCOME FOLLOWING AN ACUTE CORONARY SYNDROME MANAGED CONSERVATIVELY: RESULTS FROM THE ISACS-TC
  45. Exploring In-hospital Death from Myocardial Infarction in Eastern Europe: From the International Registry of Acute Coronary Syndromes in Transitional Countries (ISACS-TC); on the Behalf of the Working Group on Coronary Pathophysiology & Microcirculatio...
  46. Epidemiology and the physiopathological link between depression and cardiovascular disease
  47. Comparative care and outcomes for acute coronary syndromes in Central and Eastern European Transitional countries: A review of the literature
  48. 2014 ESC/EACTS Guidelines on myocardial revascularization
  49. Effects of Angiotensin-Converting Enzyme Inhibitors and Beta Blockers on Clinical Outcomes in Patients With and Without Coronary Artery Obstructions at Angiography (from a Register-Based Cohort Study on Acute Coronary Syndromes)
  50. Corrigendum to: '2013 ESC guidelines on the management of stable coronary artery disease'
  51. ROUTINE PERCUTANEOUS CORONARY INTERVENTION VERSUS MEDICAL THERAPY IN CLINICAL PRACTICE: THE ISACS-TC REGISTRY
  52. Guía de Práctica Clínica de la ESC 2013 sobre diagnóstico y tratamiento de la cardiopatía isquémica estable
  53. Acute coronary syndrome in octogenarian patients: results from the international registry of acute coronary syndromes in transitional countries (ISACS-TC) registry
  54. Clinical profile of patients with no-reperfusion therapy in Bosnia and Herzegovina and Serbia
  55. Gender differences in case fatality rates of acute myocardial infarction in Serbia
  56. Perspectives: The burden of cardiovascular risk factors and coronary heart disease in Europe and worldwide
  57. Management of heart failure complicating acute coronary syndromes in Montenegro and Serbia
  58. Perspectives: Rationale and design of the ISACS-TC (International Survey of Acute Coronary Syndromes in Transitional Countries) project
  59. Wytyczne ESC dotyczące postępowania w stabilnej chorobie wieńcowej w 2013 roku
  60. Endothelial Dysfunction and Long-Term Prognosis of Variant Angina
  61. Endothelial dysfunction versus early atherosclerosis: A study with high resolution imaging
  62. Sex Differences in Biomarkers for Predicting Cardiovascular and Coronary Events
  63. 2013 ESC guidelines on the management of stable coronary artery disease
  64. Presentation, management and outcomes of ischaemic heart disease in women
  65. UNFRACTIONED HEPARIN/CLOPIDOGREL INTERACTION IN PATIENTS WITH STEMI NOT UNDERGOING REPERFUSION
  66. Methods to investigate coronary microvascular function in clinical practice
  67. Coronary revascularisation in stable patients after an acute coronary syndrome: a propensity analysis of early invasive versus conservative management in a register-based cohort study
  68. Cardiac Syndrome X Prognosis
  69. The Impact of Treatment on the Pathophysiologic Mechanisms Linking Coronary Heart Disease and Depression
  70. Heart Rate Variability Today
  71. Third Universal Definition of Myocardial Infarction
  72. Third universal definition of myocardial infarction
  73. Third Universal Definition of Myocardial Infarction
  74. Relations between professional medical associations and healthcare industry, concerning scientific communication and continuing medical education: a Policy Statement from the European Society of Cardiology
  75. Políticas de conflito de interesses e exigências para divulgação em Revistas Científicas de Cardiologia Nacionais da Sociedade Europeia de Cardiologia
  76. Conflicts of interest policies and disclosure requirements among European Society of Cardiology national cardiovascular journals
  77. Conflict of interest policies and disclosure requirements among European Society of Cardiology national cardiovascular journals
  78. Políticas de conflictos de intereses y requisitos para su declaración en las revistas cardiovasculares nacionales de la Sociedad Europea de Cardiología
  79. Conflict of Interest Policies and Disclosure Requirements Among European Society of Cardiology National Cardiovascular Journals
  80. Conflict of interest policies and disclosure requirements among European Society of Cardiology National Cardiovascular Journals
  81. Conflict of interest policies and disclosure requirements among European Society of Cardiology national cardiovascular journals
  82. Conflict of interest policies and disclosure requirements among European Society of Cardiology National Cardiovascular Journals
  83. Relations between professional medical associations and the health-care industry, concerning scientific communication and continuing medical education: a Policy Statement from the European Society of Cardiology
  84. CORONARY REVASCULARIZATION IN PATIENTS THAT BECOME STABLE
  85. NO-REFLOW PHENOMENON IN ACUTE MYOCARDIAL INFARCTION IS RELATED TO A PERSISTENT INCREASE OF SYMPATHETIC TONE
  86. CLINICAL FEATURES AND PSYCHOLOGICAL FACTORS IN WOMEN WITH CORONARY HEART DISEASE
  87. Bridging the gender gap: Insights from a contemporary analysis of sex-related differences in the treatment and outcomes of patients with acute coronary syndromes
  88. Conflict of Interest Policies and Disclosure Requirements Among European Society of Cardiology National Cardiovascular Journals
  89. Conflict of Interest Policies and Disclosure Requirements Among European Society of Cardiology National Cardiovascular Journals
  90. Regarding “Depressive symptoms are related to progression of coronary calcium in midlife women: The Study of Women's Health Across the Nation (SWAN) Heart Study”
  91. Depression, inflammation and therapy: Which way is right?
  92. Factors influencing underutilization of evidence-based therapies in women
  93. Editorʼs page
  94. Glycoprotein IIb/IIIa Antagonists in Acute Coronary Syndromes Undergoing PCI: A Long Way to Select Optimal Agent and Route
  95. Ischaemic heart disease in women: are there sex differences in pathophysiology and risk factors?: Position Paper from the Working Group on Coronary Pathophysiology and Microcirculation of the European Society of Cardiology
  96. Further insights into syndrome X
  97. Diagnosis and Treatment of Heart Disease: Are Women Different From Men?
  98. Gender Bias in Acute Coronary Syndromes
  99. THE CORONARY WALL BY OCT IN PATIENTS WITH CORONARY SPASM
  100. UNDERUTILIZATION INFLUENCING FACTORS OF EVIDENCE BASED THERAPIES IN WOMEN
  101. Women and Ischemic Heart Disease
  102. In-hospital case fatality rates for acute myocardial infarction in Romania
  103. A review of methods for assessment of coronary microvascular disease in both clinical and experimental settings
  104. Abnormalities of cardiac autonomic nervous activity correlate with expansive coronary artery remodeling
  105. Effect of Percutaneous Coronary Intervention on Coronary Blood Flow at Rest in Myocardial Sites Remote from the Intervention Site in Patients With Stable Angina Pectoris
  106. Barriers to clinical risk scores adoption
  107. Correction
  108. Angina, “Normal” Coronary Angiography, and Vascular Dysfunction: Risk Assessment Strategies
  109. Unanswered Questions for Management of Acute Coronary Syndrome
  110. Sources of Error and Interpretation of Plaque Morphology by Optical Coherence Tomography
  111. Takayasu’s arteritis: A case report and a brief review of the literature
  112. Women, ‘non-specific’ chest pain, and normal or near-normal coronary angiograms are not synonymous with favourable outcomeThe opinions expressed in this article are not necessarily those of the Editors of the European Heart Journal or of the European S...
  113. Coronary spasm reflects inputs from adjacent esophageal system
  114. Endothelial function and the prediction of CVD in diabetes
  115. The beneficial effect of insulin, glucose, and dipyridamole on regional left ventricular function early after acute myocardial infarction
  116. Angina With “Normal” Coronary Arteries—Reply
  117. Angina With “Normal” Coronary Arteries
  118. Normal Coronary Arteries: Clinical Implications and Further Classification
  119. Angina With “Normal” Coronary Arteries
  120. Changes in autonomic nervous system activity: spontaneous versus balloon-induced myocardial ischaemia
  121. Risk stratification in acute coronary syndrome: focus on unstable angina/non-ST segment elevation myocardial infarction
  122. Effect of pravastatin on myocardial perfusion after percutaneous transluminal coronary angioplasty
  123. Endothelial Function Predicts Future Development of Coronary Artery Disease: A Study of Women With Chest Pain and Normal Coronary Angiograms
  124. 1103-197 Chlamydia pneumoniae-heat shock protein 60 induces a highly specific persistent immune response in patients with unstable angina independently from IgG and IgA seropositivity
  125. Angiotensin-Converting Enzyme Inhibitors and 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase in Cardiac Syndrome X: Role of Superoxide Dismutase Activity
  126. Valsartan, Captopril, or Both in Myocardial Infarction Complicated by Heart Failure, Left Ventricular Dysfunction, or Both
  127. Parasympathetic failure and risk of subsequent coronary events in unstable angina and non-ST-segment elevation myocardial infarction
  128. From syndrome X to coronary artery disease
  129. P3000 Electrocardiogram-based non-invasive strategy to reduce hospital stay for patients with low risk unstable angina and non-ST-elevation myocardial infarction
  130. 2063 Heart-rate variability reflects the severity of coronary artery disease
  131. P3284 Ischaemia during electrocardiogram monitoring identifies patients with acute coronary syndromes at high risk of post-discharge adverse cardiac events: a 5-year prospective analysis
  132. P3298 The paradox of oxidative stress in coronary artery disease. A study on superoxide dismutase activity at rest and during stress test
  133. Physical activity exerts benefits in coronary heart disease through autonomic nervous system modulation
  134. β-Endorphin modulation of pressor response to hyperventilation in hypertensive patients
  135. Stress echo in chest pain unit: the SPEED (Stress Pharmacologic Echocardiography in Emergency Department) trial
  136. Antioxidant therapy can influence the recovery of left atrial contraction after external electrical cardioversion Grazia Maria Costa, Carmine Pizzi, Barbara Bresciani, Luca Gabrieli, Danilo Cervellati, Raffaele Bugiardini. Dept Cardiology, Imola Hospit...
  137. Educational training program as treatment of patients with vasovagal syncope Danilo Cervellati, Carmine Pizzi, Giorgio Visani, Grazia M. Costa, Luca Gabrielli, Alberico Borghi, Raffaele Bugiardini. Dept. Cardiology, Imola Hospital University of Bologna...
  138. Evidence of oxidative stress in patients with angina and normal coronary arteries: Role of statins and ace-inhibitors Carmine Pizzi, Grazia Maria Costa, Barbara Bresciani, Milena Gentile, Carlo Tumscitz, Bugiardini Raffaele. Dep cardiology Imola Hospit...
  139. Intravenous sotalol in refractory supraventricular tachyarrhythmias in patients with left ventricular dysfunction
  140. Unstable angina and non Q-wave myocardial infarction. Early risk stratification: role of silent ischemia and coronary morphology
  141. Unstable angina: Prognosis of the individual patient
  142. Relationship Between Plasma Endothelin-1 Levels and Myocardial Ischemia Induced by Exercise Testing
  143. Transient sympathovagal imbalance triggers “ischemic” sudden death in patients undergoing electrocardiographic Holter monitoring
  144. Different patterns of heart rate variability in patients suffering sudden death while wearing holter monitoring: The role of concomitant ST segment changes
  145. Influence of pain on heart rate variability during Holter monitoring
  146. Dynamic factors in the genesis of myocardial ischaemia
  147. Relation of severity of symptoms to transient myocardial ischemia and prognosis in unstable angina
  148. Reply
  149. Epicardial Coronary Artery Responses In Patients With Angina And Normal Coronary Arteriograms
  150. Changes in pulmonary hemodynamics predict benefits in exercise capacity after ACE inhibition in patients with mild to moderate congestive heart failure
  151. The paradox of nitrates in patients with angina pectoris and angiographically normal coronary arteries
  152. Vasotonic angina: A spectrum of ischemic sysdroms involving function abnormalities of the epicardial and microvascular coronary circulation
  153. Epicardial coronary artery reactivity in patients with syndrome X
  154. Coronary hemodynamic effects of systemic thrombolysis in patients with unstable angina
  155. Prognostic significance of silent myocardial ischemia in variant angina pectoris
  156. Angiographic morphology in unstable angina and its relation to transient myocardial ischemia and hospital outcome
  157. Variant angina: Interaction between abnormal and diffuse coronary vasoconstriction and atherosclerosis
  158. Circadian variation in variant angina: A marker of pure coronary spasm
  159. The role of collateral circulation in the occurrence of postinfarction ischemia following thrombolysis
  160. Coronary hemodynamics following aminophylline in coronary artery disease
  161. Invasive monitoring of coronary blood flow in acute myocardial infarction: pathogenetic and therapeutic relevance
  162. Comparison of verapamil versus propranolol therapy in syndrome X
  163. Effects of iloprost (ZK 36374), a prostacyclin derivative, on platelet function after ischaemic exercise in patients with stable angina pectoris
  164. Effect of oral levodopa and carbidopa on coronary spasm in variant angina pectoris
  165. Myocardial ischemia during intravenous prostacyclin administration: Hemodynamic findings and precautionary measures
  166. Evolution Toward Necrosis During Intermittent Periods of Myocardial Ischemia: Cytoprotective Effects of Iloprost, a Stable Prostacyclin Analogue
  167. Effects of iloprost, a stable prostacyclin analog, on exercise capacity and platelet aggregation in stable angina pectoris
  168. Differential transmyocardial platelet behavior in response to pacing and ergonovine-induced myocardial ischemia
  169. Myocardial ischemia induced by prostacyclin and iloprost
  170. Different susceptibility to myocardial ischemia provoked by hyperventilation and cold pressor test in exertional and variant angina pectoris
  171. Evaluation of the effects of catheter sampling for the study of platelet behavior in the pulmonary and coronary circulation
  172. Ergonovine-induced myocardial ischemia: no role for serotonergic receptors?
  173. Differential Intramyocardial Platelet Behaviour in Different Forms of Ischemia
  174. The ischaemic area: evaluation and attempts to limit extension
  175. Diagnostic visualization of ischaemic myocardium
  176. Relationship between different degrees of underperfusion and myocardial behaviour: Electrocardiographic, metabolic and enzymatic findings
  177. Studies on alkaline phosphatase isoenzymes in hepatic diseases. Relation to γ-glutamyltransferase
  178. Alkaline Phosphatase Isoenzymes in Liver Cirrhosis